Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hussein M Khaled

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Future Science OA|October 15, 2019
Impact of serum levels of IL-18 and soluble IL-2 receptor on the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP regimenHussein M Khaled, Thoraya M Abdelhamid, Fouad M Abu-Taleb, et al.
Acta Poloniae Pharmaceutica|March 10, 2010
Immunostimulatory effects of extract of Pulicaria crispa before and after Schistosoma mansoni infectionAmany S Maghraby, Nagwa Shalaby, Howida I Abd-Alla, et al.
Clinical Laboratory|July 14, 2021
Prognostic Values of MicroRNA-21 and Ki-67 in Diffuse Large B-Cell Lymphoma Patients: Egyptian ExperienceHend A Asker, Eman N Khorshed, Mohamed R Ahmed, et al.
BMC Cancer|January 28, 2009
Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancerHussein M Khaled, Abeer A Bahnassy, Amira A Raafat, et al.
European Journal of Haematology|October 15, 2010
Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54)Igor Aurer, Houchingue Eghbali, John Raemaekers, et al.
Journal of Translational Medicine|January 5, 2011
Cathepsin B: a potential prognostic marker for inflammatory breast cancerMohamed A Nouh, Mona M Mohamed, Mohamed El-Shinawi, et al.
Journal of Gastroenterology and Hepatology|December 22, 2004
Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinomaAbdel-Rahman N Zekri, Abeer A Bahnassy, Mohamed Hafez, et al.
The Lancet. Oncology|April 9, 2013
Developing cancer control plans in Africa: examples from five countriesDaniela Cristina Stefan, Ahmed M Elzawawy, Hussein M Khaled, et al.
Journal of the Egyptian National Cancer Institute|February 18, 2005
Gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: National Cancer Institute Cairo experienceRabab M Gaafar, Reda Hamza, Hussein M Khaled, et al.
BMC Research Notes|October 31, 2008
Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: preliminary studyAbdel-Rahman N Zekri, Mohamed M Hafez, Abeer A Bahnassy, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Future Science OA|October 15, 2019
Impact of serum levels of IL-18 and soluble IL-2 receptor on the clinical outcome of patients with diffuse large B-cell lymphoma treated with R-CHOP regimenHussein M Khaled, Thoraya M Abdelhamid, Fouad M Abu-Taleb, et al.
Acta Poloniae Pharmaceutica|March 10, 2010
Immunostimulatory effects of extract of Pulicaria crispa before and after Schistosoma mansoni infectionAmany S Maghraby, Nagwa Shalaby, Howida I Abd-Alla, et al.
Clinical Laboratory|July 14, 2021
Prognostic Values of MicroRNA-21 and Ki-67 in Diffuse Large B-Cell Lymphoma Patients: Egyptian ExperienceHend A Asker, Eman N Khorshed, Mohamed R Ahmed, et al.
BMC Cancer|January 28, 2009
Clinical significance of altered nm23-H1, EGFR, RB and p53 expression in bilharzial bladder cancerHussein M Khaled, Abeer A Bahnassy, Amira A Raafat, et al.
European Journal of Haematology|October 15, 2010
Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma--EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54)Igor Aurer, Houchingue Eghbali, John Raemaekers, et al.
Journal of Translational Medicine|January 5, 2011
Cathepsin B: a potential prognostic marker for inflammatory breast cancerMohamed A Nouh, Mona M Mohamed, Mohamed El-Shinawi, et al.
Journal of Gastroenterology and Hepatology|December 22, 2004
Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinomaAbdel-Rahman N Zekri, Abeer A Bahnassy, Mohamed Hafez, et al.
The Lancet. Oncology|April 9, 2013
Developing cancer control plans in Africa: examples from five countriesDaniela Cristina Stefan, Ahmed M Elzawawy, Hussein M Khaled, et al.
Journal of the Egyptian National Cancer Institute|February 18, 2005
Gemcitabine and cisplatin in the treatment of advanced non-small cell lung cancer: National Cancer Institute Cairo experienceRabab M Gaafar, Reda Hamza, Hussein M Khaled, et al.
BMC Research Notes|October 31, 2008
Genetic profile of Egyptian hepatocellular-carcinoma associated with hepatitis C virus Genotype 4 by 15 K cDNA microarray: preliminary studyAbdel-Rahman N Zekri, Mohamed M Hafez, Abeer A Bahnassy, et al.
Pageof 4